Healthcare Industry News

That’s the key takeaway from the annual 2020 Aflac WorkForces Report, which takes a magnifying glass to how employees and employers expect to approach health care benefits enrollment each year.

Johnson & Johnson’s latest climate goals build on the legacy and achievement of our previous efforts, while accelerating action as part of the larger movement by the private sector, along with governments and civil society, to ramp up the ambition and implementation of climate goals during this new UN Decade of Action.

Johnson & Johnson (NYSE: JNJ) (the Company) recently announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies.

We’re pleased to announce that based on interim results from our ongoing studies, the Janssen Pharmaceutical Companies of Johnson & Johnson are launching ENSEMBLE, a large-scale, multi-country Phase 3 trial of a single dose of our vaccine candidate.

As schools reopen—and sometimes close again—what have we learned about the risks of in-person learning? Lisa Ling speaks to school nurse Robin Cogan and pediatrician Dr. Sam Maldonado to find answers and debunk myths around kids and COVID-19.

The Healthcare Plastics Recycling Council (HPRC) is pleased to announce the appointment of The Ohio State University Wexner Medical Center to its Healthcare Facility Advisory Board (HFAB), a role intended to help the council set priorities and steer the agenda toward its mission of inspiring and enabling sustainable, cost-effective recycling solutions for plastic products and materials used in the delivery of healthcare.

When New York City became the epicenter for COVID-19, Medtronic took the initiative to help transform a well-renowned convention center into a source of hope.

Although uncertainty and fear still ripple throughout the world, Medtronic continues to create tools and resources that encourage people to seek care during the pandemic.

The market for medical electronics today represents a comparatively small share of the nation’s nearly $200 billion in overall health expenses – about 5.2% in 2019. But the value it brings to the practice of medicine is disproportionately large and growing rapidly.

Johnson & Johnson announced that we, alongside eight other companies working on investigational COVID-19 vaccines, are signing a #WeStandWithScience pledge committed to upholding the integrity of the scientific process as we work towards potential global regulatory filings and approvals of the first vaccines for COVID-19.